Registry for Long-Term Study of Treatments and Outcomes in Adults with Acute Coronary Syndrome

What this Trial Is About

This research focuses on patients with acute coronary syndrome ACS, a leading cause of death worldwide. It aims to create an ongoing registry to evaluate the long-term effects of diagnostics, treatments, and devices used for ACS in real-world clinical practice. The study addresses gaps left by traditional randomized controlled trials by capturing data from routine care and broader patient populations to improve cardiovascular care and quality of life. The study uses a nonrandomized observational design to collect detailed clinical and possibly genetic information from patients with ACS. This registry allows evaluation of various therapies, devices, and diagnostic tools used in daily practice. It also examines follow-up care pathways, risk score usage for medication duration, and adherence to treatment guidelines, aiming to enhance personalized medicine and secondary prevention. Participants provide information during routine clinical visits, with data collected prospectively and followed over time. Researchers monitor outcomes such as mortality, recurrent ischemic events, hospital admissions, and quality of life. The main measure is the number of participants tracked at three years. This long-term observation helps evaluate the effectiveness and safety of treatments in everyday clinical settings and supports ongoing improvements in ACS care.

Future Optimal Research and Care Evaluation